TD Waterhouse Canada
PROF icon

TD Waterhouse Canada’s Profound Medical PROF Stock Holding History

TD Waterhouse Canada’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$888K Buy
161,631
+23,521
+17% +$160K ﹤0.01% 742
2026
Q2 		$934K Sell
138,110
-4,931
-3% -$33.2K ﹤0.01% 724
2026
Q1 		$902K Buy
143,041
+65,548
+85% +$453K ﹤0.01% 709
2025
Q4 		$582K Buy
77,493
+2,200
+3% +$14.1K ﹤0.01% 664
2025
Q3 		$356K Buy
75,293
+19,220
+34% +$98.1K ﹤0.01% 757
2025
Q2 		$342K Buy
56,073
+14,920
+36% +$78.9K ﹤0.01% 727
2025
Q1 		$234K Buy
41,153
+15,751
+62% +$109K ﹤0.01% 761
2024
Q4 		$182K Buy
25,402
+1,515
+6% +$11.6K ﹤0.01% 819
2024
Q3 		$188K Sell
23,887
-299
-1% -$2.7K ﹤0.01% 784
2024
Q2 		$203K Buy
24,186
+8,929
+59% +$72K ﹤0.01% 765
2024
Q1 		$166K Sell
15,257
-1,153
-7% -$9.6K ﹤0.01% 804
2023
Q4 		$158K Buy
16,410
+15,010
+1,072% +$143K ﹤0.01% 723
2023
Q3 		$18.1K Hold
1,400
– – ﹤0.01% 1111
2023
Q2 		$23.6K Buy
1,400
+400
+40% +$4.96K ﹤0.01% 1095
2023
Q1 		$12.8K Sell
1,000
-270
-21% -$3.12K ﹤0.01% 1173
2022
Q4 		$19K Hold
1,270
– – ﹤0.01% 1105
2022
Q3 		$6.74K Hold
1,270
– – ﹤0.01% 1296
2022
Q2 		$12K Buy
1,270
+270
+27% +$2.14K ﹤0.01% 1212
2022
Q1 		$11K Hold
1,000
– – ﹤0.01% 1307
2021
Q4 		$13.5K Buy
+1,000
New +$12.5K ﹤0.01% 1286

Other funds holding PROF

Ring Mountain Capital
Ring Mountain Capital Tiburon, California $245M AUM 48.62% 1-Year Est. Return
Crescent Grove Advisors
Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Penbrook Management
Penbrook Management New York $169M AUM 32.52% 1-Year Est. Return

TD Waterhouse Canada's PROF Position: Q3 2026 in Review

TD Waterhouse Canada increased its Profound Medical (PROF) stake by 17% in Q3 2026, buying an estimated $160K and bringing the position to 161,631 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

TD Waterhouse Canada first reported a position in PROF in Q4 2021 and has held it in 20 quarters since. The position peaked at $934K in Q2 2026. 6 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • TD Waterhouse Canada held 161,631 shares of Profound Medical worth $888K as of Q3 2026.
  • TD Waterhouse Canada bought 23,521 Profound Medical shares in Q3 2026, an estimated $160K.
  • Profound Medical made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q3 2026, its #742 holding.
  • TD Waterhouse Canada first reported a position in Profound Medical in Q4 2021 and has held it in 20 quarters since.
  • TD Waterhouse Canada's Profound Medical position peaked at $934K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on TD Waterhouse Canada's 13F filing for Q3 2026, filed 16 Oct 2026.